First human tests: new drug for kidney health shows early promise
NCT ID NCT02653014
Summary
This early-stage study tested the safety of an experimental drug called KBP-5074 in healthy volunteers and people with mild to moderate kidney problems. Researchers gave increasing doses to 26 participants to see how their bodies handled the drug and to check for side effects. The goal was to gather information to help design future studies, not to treat any specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research by Design, LLC
Evergreen Park, Illinois, 60805, United States
Conditions
Explore the condition pages connected to this study.